Near term Outlook For Akers Biosciences Inc. (NASDAQ:AKER)


Akers Biosciences Inc. (NASDAQ:AKER) closed its last session at $0.18. The stock traded within a range of $0.160 and $0.180. The company operates in the Healthcare sector with a market capitalization of 5530. Trading volume for Akers Biosciences Inc. was 10.73 Million in its previous trading session. Currently, Akers Biosciences Inc. (NASDAQ:AKER) has an average volume of 2.63 Million.

Company Profile

Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company’s products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.

Analyst Views

Akers Biosciences Inc. (NASDAQ:AKER) received a Buy rating from 0 analysts. 0 analysts gave its stock an Outperform rating. 0 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.

Akers Biosciences Inc. (NASDAQ:AKER) touched its 1-Year High price of $2.900 on 03/28/17 and its 1-Year Low price of $0.120 on 12/22/17.

EPS & Financials

For the current quarter, 1 analysts are projecting a mean EPS of $0.06/share. According to their observations and findings, the stock could provide a high EPS of $0.06/share and a low EPS of $0.06/share.

Analysts believe that the company has the potential to earn average revenue of $2.1 Million for the current quarter. According to their predictions high & low revenue estimates are 2.1 Million and 2.1 Million respectively.

Technical Analysis

By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with HIGH volatility. Akers Biosciences Inc. (NASDAQ:AKER) has a 20-Day average volume of 7.26 Million. According to today’s trading volume Akers Biosciences Inc. is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BULLISH territory while an analysis of the last 40-Day trend shows a BEARISH signal. The 100-Day trend also shows a BEARISH trend as well.

The company currently has an insider ownership of 0.8 Percent and Institutional ownership of 5.7 Percent. The return on assets stands at -74.8%, Return on Equity currently is -99.9% and the Return on Investment value is -97.9%.

Akers Biosciences Inc. (NASDAQ:AKER) gross margin percentage stands at 61.9% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. The stock is currently moving below its 20-Day Simple Moving Average of -12.56% with a 50-Day Simple Moving Average of -60.41 percent. As of today, the company has a SMA200 (200-day simple moving average) of -82.62 Percent. The Stock has YTD (year to date) performance of 34.18 percent.

The TTM operating margin for the company stands at 0%. The return on invested capital is at -97.9%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.

The company’s stock is currently moving with a -ve distance from the 200 day SMA of approximately -82.62%, and has a solid year to date (YTD) performance of 34.18% which means that the stock is constantly adding to its value from the previous fiscal year end price.